Related Experiment Video
Updated: Dec 22, 2025
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
Leishmania: A Maestro in Epigenetic Manipulation of Macrophage Inflammasomes
Shaden Kamhawi1, Tiago D Serafim1
1Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Abstract:
Epigenetic manipulation of host cells by intracellular pathogens has become increasingly evident. Lecoeur et al. show us how Leishmania amazonensis inhibits macrophage inflammasomes by modifying histone H3 activation marks on NF-κB-associated gene promoters that increase the expression of inhibitors and downmodulates activators of this pathway.
Insights
Leishmania amazonensis manipulates host cells by altering histone marks, inhibiting macrophage inflammasomes. This epigenetic reprogramming increases inflammasome inhibitors and decreases activators, aiding pathogen survival.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Intracellular pathogens increasingly utilize host cell epigenetic mechanisms for survival.
- Macrophage inflammasomes are critical components of the innate immune system.
- Leishmania amazonensis is an intracellular parasite known to evade host defenses.
Purpose of the Study:
- To investigate the epigenetic mechanisms employed by Leishmania amazonensis to modulate host macrophage function.
- To elucidate how Leishmania amazonensis interferes with the macrophage inflammasome pathway.
Main Methods:
- Chromatin immunoprecipitation (ChIP) assays to analyze histone modifications.
- Quantitative PCR (qPCR) to assess gene expression levels.
- Western blotting to detect protein levels of inflammasome components and regulators.
Main Results:
- Leishmania amazonensis infection leads to specific modifications of histone H3 activation marks on NF-κB-associated gene promoters.
- The observed epigenetic changes result in increased expression of inflammasome inhibitors.
- Concurrently, Leishmania amazonensis downmodulates the expression of inflammasome activators within macrophages.
Conclusions:
- Leishmania amazonensis actively manipulates host macrophage epigenetics to suppress inflammasome activation.
- This epigenetic reprogramming is a key strategy for Leishmania evasion of innate immunity.
- Targeting these epigenetic modifications could offer novel therapeutic strategies against Leishmania infections.
